Literature DB >> 21939253

Farinamycin, a quinazoline from Streptomyces griseus.

Markus Nett1, Christian Hertweck.   

Abstract

The metabolic potential of a Streptomyces griseus strain was investigated under various cultivation conditions. After fermentation in a flour-based medium, a new quinazoline metabolite, farinamycin (1), could be isolated from the bacterium, which was previously known only for the production of phenoxazinone antibiotics. The structure of 1 illuminates the biosynthetic versatility of S. griseus, which assembles a defined set of building blocks into structurally diverse natural products.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939253     DOI: 10.1021/np2002513

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  Dandamycin and chandrananimycin E, benzoxazines from Streptomyces griseus.

Authors:  Emma C Barnes; Patricia Bezerra-Gomes; Markus Nett; Christian Hertweck
Journal:  J Antibiot (Tokyo)       Date:  2015-02-18       Impact factor: 2.649

2.  Structure and Biosynthesis of Myxofacyclines: Unique Myxobacterial Polyketides Featuring Varing and Rare Heterocycles[] *.

Authors:  Alexander Popoff; Joachim J Hug; Sebastian Walesch; Ronald Garcia; Lena Keller; Rolf Müller
Journal:  Chemistry       Date:  2021-11-05       Impact factor: 5.020

3.  New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria.

Authors:  Kyungmin Kim; Daseul Kim; Hyunjin Lee; Tae Hoon Lee; Ki-Young Kim; Hakwon Kim
Journal:  Biomedicines       Date:  2020-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.